Leptin-derived peptide, a targeting ligand for mouse brain-derived endothelial cells via macropinocytosis

Biochemical and Biophysical Research Communications

Volumn 394, Issue 3, 2010, Pages 587-592

  Tamaru, Mina ^a   Akita, Hidetaka ^a   Fujiwara, Takahiro ^a   Kajimoto, Kazuaki ^a   Harashima, Hideyoshi ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Brain endothelial cell; Cellular uptake; Leptin; Liposome; Macropinocytosis

Indexed keywords

CHLORPROMAZINE; FILIPIN; LEPTIN; LIPOSOME;

ANIMAL CELL; ARTICLE; BLOOD BRAIN BARRIER; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENDOSOME; ENDOTHELIUM CELL; LYSOSOME; MOUSE; NONHUMAN; PINOCYTOSIS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; BRAIN; ENDOSOMES; ENDOTHELIAL CELLS; LEPTIN; LIGANDS; LIPOSOMES; LYSOSOMES; MICE; PEPTIDES; PINOCYTOSIS; POLYETHYLENE GLYCOLS; RECEPTORS, LEPTIN;

EID: 77950517892     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.03.024     Document Type: Article

References (41)

1. Banks W.A. Developing drugs that can cross the blood-brain barrier: applications to Alzheimer's disease. BMC Neurosci. 9 Suppl. 3 (2008) S2
2. Pillay S., Pillay V., Choonara Y.E., Naidoo D., Khan R.A., du Toit L.C., Ndesendo V.M., Modi G., Danckwerts M.P., and Iyuke S.E. Design, biometric simulation and optimization of a nano-enabled scaffold device for enhanced delivery of dopamine to the brain. Int. J. Pharm. 382 (2009) 277-290
3. Pardridge W.M. Blood-brain barrier biology and methodology. J. Neurovirol. 5 (1999) 556-569
4. Modi G., Pillay V., Choonara Y.E., Ndesendo V.M., du Toit L.C., and Naidoo D. Nanotechnological applications for the treatment of neurodegenerative disorders. Prog. Neurobiol. 88 (2009) 272-285
5. Allen T.M., and Hansen C. Pharmacokinetics of stealth versus conventional liposomes: effect of dose. Biochim. Biophys. Acta 1068 (1991) 133-141
6. Klibanov A.L., Maruyama K., Torchilin V.P., and Huang L. Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes. FEBS Lett. 268 (1990) 235-237
7. Pardridge W.M. shRNA and siRNA delivery to the brain. Adv. Drug Deliv. Rev. 59 (2007) 141-152
8. Corti A., Curnis F., Arap W., and Pasqualini R. The neovasculature homing motif NGR: more than meets the eye. Blood 112 (2008) 2628-2635
9. Y. Chen, J.J. Wu, L. Huang, Nanoparticles targeted with NGR motif deliver c-myc siRNA and doxorubicin for anticancer therapy, Mol. Ther., in press.
10. Pan W., and Kastin A.J. Penetration of neurotrophins and cytokines across the blood-brain/blood-spinal cord barrier. Adv. Drug Deliv. Rev. 36 (1999) 291-298
11. Pardridge W.M., Frank H.J., Cornford E.M., Braun L.D., Crane P.D., and Oldendorf W.H. Neuropeptides and the blood-brain barrier. Adv. Biochem. Psychopharmacol. 28 (1981) 321-328
12. Wolfgang M.J., and Lane M.D. Control of energy homeostasis: role of enzymes and intermediates of fatty acid metabolism in the central nervous system. Annu. Rev. Nutr. 26 (2006) 23-44
13. Koistinen H.A., Karonen S.L., Iivanainen M., and Koivisto V.A. Circulating leptin has saturable transport into intrathecal space in humans. Eur. J. Clin. Invest. 28 (1998) 894-897
14. Banks W.A., Kastin A.J., Huang W., Jaspan J.B., and Maness L.M. Leptin enters the brain by a saturable system independent of insulin. Peptides 17 (1996) 305-311
15. Banks W.A., Niehoff M.L., Martin D., and Farrell C.L. Leptin transport across the blood-brain barrier of the Koletsky rat is not mediated by a product of the leptin receptor gene. Brain Res. 950 (2002) 130-136
16. Golden P.L., Maccagnan T.J., and Pardridge W.M. Human blood-brain barrier leptin receptor. Binding and endocytosis in isolated human brain microvessels. J. Clin. Invest. 99 (1997) 14-18
17. Maresh G.A., Maness L.M., Zadina J.E., and Kastin A.J. In vitro demonstration of a saturable transport system for leptin across the blood-brain barrier. Life Sci. 69 (2001) 67-73
18. Pan W., Hsuchou H., Tu H., and Kastin A.J. Developmental changes of leptin receptors in cerebral microvessels: unexpected relation to leptin transport. Endocrinology 149 (2008) 877-885
19. Tu H., Kastin A.J., Hsuchou H., and Pan W. Soluble receptor inhibits leptin transport. J. Cell. Physiol. 214 (2008) 301-305
20. Peelman F., Iserentant H., De Smet A.S., Vandekerckhove J., Zabeau L., and Tavernier J. Mapping of binding site III in the leptin receptor and modeling of a hexameric leptin leptin receptor complex. J. Biol. Chem. 281 (2006) 15496-15504
21. Peelman F., Van Beneden K., Zabeau L., Iserentant H., Ulrichts P., Defeau D., Verhee A., Catteeuw D., Elewaut D., and Tavernier J. Mapping of the leptin binding sites and design of a leptin antagonist. J. Biol. Chem. 279 (2004) 41038-41046
22. Barrett G.L., Trieu J., and Naim T. The identification of leptin-derived peptides that are taken up by the brain. Regul. Pept. 155 (2009) 55-61
23. Otvos Jr. L., Terrasi M., Cascio S., Cassone M., Abbadessa G., De Pascali F., Scolaro L., Knappe D., Stawikowski M., Cudic P., Wade J.D., Hoffmann R., and Surmacz E. Development of a pharmacologically improved peptide agonist of the leptin receptor. Biochim. Biophys. Acta 1783 (2008) 1745-1754
24. Lu J., Jeon E., Lee B.S., Onyuksel H., and Wang Z.J. Targeted drug delivery crossing cytoplasmic membranes of intended cells via ligand-grafted sterically stabilized liposomes. J. Control Release 110 (2006) 505-513
25. Kastin A.J., Pan W., Maness L.M., Koletsky R.J., and Ernsberger P. Decreased transport of leptin across the blood-brain barrier in rats lacking the short form of the leptin receptor. Peptides 20 (1999) 1449-1453
26. Hileman S.M., Tornoe J., Flier J.S., and Bjorbaek C. Transcellular transport of leptin by the short leptin receptor isoform ObRa in Madin-Darby Canine kidney cells. Endocrinology 141 (2000) 1955-1961
27. Tu H., Pan W., Feucht L., and Kastin A.J. Convergent trafficking pattern of leptin after endocytosis mediated by ObRa-ObRd. J. Cell. Physiol. 212 (2007) 215-222
28. Mislick K.A., and Baldeschwieler J.D. Evidence for the role of proteoglycans in cation-mediated gene transfer. Proc. Natl. Acad. Sci. USA 93 (1996) 12349-12354
29. Mounkes L.C., Zhong W., Cipres-Palacin G., Heath T.D., and Debs R.J. Proteoglycans mediate cationic liposome-DNA complex-based gene delivery in vitro and in vivo. J. Biol. Chem. 273 (1998) 26164-26170
30. Belouzard S., and Rouille Y. Ubiquitylation of leptin receptor OB-Ra regulates its clathrin-mediated endocytosis. EMBO J. 25 (2006) 932-942
31. Wang L.H., Rothberg K.G., and Anderson R.G. Mis-assembly of clathrin lattices on endosomes reveals a regulatory switch for coated pit formation. J. Cell Biol. 123 (1993) 1107-1117
32. Hewlett L.J., Prescott A.R., and Watts C. The coated pit and macropinocytic pathways serve distinct endosome populations. J. Cell Biol. 124 (1994) 689-703
33. Lamaze C., and Schmid S.L. The emergence of clathrin-independent pinocytic pathways. Curr. Opin. Cell Biol. 7 (1995) 573-580
34. Khalil I.A., Kogure K., Futaki S., Hama S., Akita H., Ueno M., Kishida H., Kudoh M., Mishina Y., Kataoka K., Yamada M., and Harashima H. Octaarginine-modified multifunctional envelope-type nanoparticles for gene delivery. Gene Ther. 14 (2007) 682-689
35. Khalil I.A., Kogure K., Futaki S., and Harashima H. High density of octaarginine stimulates macropinocytosis leading to efficient intracellular trafficking for gene expression. J. Biol. Chem. 281 (2006) 3544-3551
36. Wadia J.S., Stan R.V., and Dowdy S.F. Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis. Nat. Med. 10 (2004) 310-315
37. Guest C.B., Chakour K.S., and Freund G.G. Macropinocytosis is decreased in diabetic mouse macrophages and is regulated by AMPK. BMC Immunol. 9 (2008) 42
38. Malyukova I., Murray K.F., Zhu C., Boedeker E., Kane A., Patterson K., Peterson J.R., Donowitz M., and Kovbasnjuk O. Macropinocytosis in Shiga toxin 1 uptake by human intestinal epithelial cells and transcellular transcytosis. Am. J. Physiol. Gastrointest. Liver Physiol. 296 (2009) G78-G92
39. Ragnarsson E.G., Schoultz I., Gullberg E., Carlsson A.H., Tafazoli F., Lerm M., Magnusson K.E., Soderholm J.D., and Artursson P. Yersinia pseudotuberculosis induces transcytosis of nanoparticles across human intestinal villus epithelium via invasin-dependent macropinocytosis. Lab. Invest. 88 (2008) 1215-1226
40. Simionescu M., Popov D., and Sima A. Endothelial transcytosis in health and disease. Cell Tissue Res. 335 (2009) 27-40
41. Wolburg H., Noell S., Mack A., Wolburg-Buchholz K., and Fallier-Becker P. Brain endothelial cells and the glio-vascular complex. Cell Tissue Res. 335 (2009) 75-96